In a nutshell The aim of this study was to investigate the effect of licogliflozin on body weight and gut hormones in patients with obesity with and without type 2 diabetes (T2D). The main finding of the study was that licogliflozin treatment resulted in weight loss and favorable metabolic changes in these patients. Some background Obesity is an...
Read MoreDiabetes mellitus Posts on Medivizor
High fiber diet and diabetic kidney disease
In a nutshell The aim of this study was to investigate the effect of fiber in the diet on diabetic kidney disease. The main outcome of the study was that a vegetarian dietary pattern may have a beneficial effect on kidney function. Some background Diet and lifestyle changes are a major part of treatment for both type 1 (T1D) and type 2 diabetes (T2D)....
Read MoreHaving trouble losing weight? The cause could be your gut bacteria
You’ve followed the diets, you’ve increased your exercise, and you still can’t lose weight. The problem may be related to the composition of your gut bacteria. Gut Bacteria and Weight Loss In a study published in Mayo Clinic Proceedings, researchers found evidence pointing to gut bacteria, “gut microbiota” hindering weight...
Read MoreSotagliflozin and blood sugar control in patients with type 1 diabetes
In a nutshell The aim of this study was to examine the effects of sotagliflozin added to insulin on blood sugar levels in patients with type 1 diabetes (T1D). The main finding of the study was that sotagliflozin and insulin together improved blood sugar control in T1D. Some background The main treatment of T1D is insulin (the hormone...
Read MoreCanagliflozin versus sitagliptin in type 2 diabetes
In a nutshell The aim of this study was to compare blood sugar control and weight loss in patients with type 2 diabetes (T2D) who were treated with canagliflozin compared to sitagliptin. The main finding was that patients treated with canagliflozin had better blood sugar control and greater weight loss than those treated with sitagliptin. Some...
Read MoreHypoglycemia and breastfeeding in women with type 1 diabetes
In a nutshell The aim of this study was to evaluate blood sugar levels during breastfeeding in mothers with type 1 diabetes (T1D). The main finding of the study was that breastfeeding at night time rarely caused hypoglycemia in comparison to women with T1D that were not breastfeeding. Some background The World Health Organization recommends...
Read MoreDoes empagliflozin help lower blood pressure in patients with diabetes and high night time blood pressure?
In a nutshell The aim of this study was to monitor blood pressure changes with empagliflozin (Jardiance) treatment and normal blood pressure treatment in patients with type 2 diabetes (T2D) and uncontrolled night time high blood pressure. The main finding of the study was that these patients had reductions in their blood pressure when empagliflozin was...
Read MoreIs it better to reduce basal insulin rate or remove insulin pump before exercise in type 1 diabetes?
In a nutshell The aim of this study was to investigate if reducing basal insulin rate (BRR) 90-minutes before exercise was better at preventing hypoglycemia (dangerously low blood glucose) than suspending the insulin pump (pump suspension; PS) in type 1 diabetes (T1D). The main finding was that BRR 90-minutes before exercise improved blood glucose...
Read MoreResveratrol and diabetic kidney disease
In a nutshell This study aimed to investigate the effects of resveratrol on diabetic kidney disease. The main finding of the study was that resveratrol reduced the amount of protein lost in the urine in diabetic kidney disease. Some background Diabetic kidney disease (nephropathy) is a common complication of diabetes. One of the ways to measure kidney...
Read MoreDoes canagliflozin increase the risk of bone fractures in patients with type 2 diabetes?
In a nutshell This study aimed to investigate the effect of canagliflozin (Invokana) use on bone fracture risk in patients with type 2 diabetes (T2D). The main finding of the study was that there was no increased risk of bone fractures with canagliflozin use. Some background Canagliflozin is an SGLT-2 inhibitor, used to treat T2D. It works by...
Read MoreDental Health and a Diabetes-Friendly Recipe
Dental health is a critical component of personal heath. For people living with diabetes, dental care is especially important since diabetes can compromise your immune system. There are between 200 and 300 bacteria in your mouth so remembering to brush at least twice a day needs to be part of your daily ritual. Although it is counter-intuitive, choosing a...
Read MoreThe relationship between insulin dose and risk of heart disease in type 1 diabetes
In a nutshell The aim of the study was to look at the relationship between insulin dose and risk of cardiovascular disease (CVD) in type 1 diabetes (T1D). The main finding of the study was that higher insulin doses are associated with CVD risk factors but not with increased CVD events. Some background Patients with T1D have an increased risk of CVD...
Read More
